Global Kidney Cancer Market Growth (Status and Outlook) 2018-2023

SKU ID : LPI- 12469728

Publishing Date : 22-Oct-2018

No. of pages : 132

PRICE
3660
7320


  • Kidney cancer is a type of cancer that starts in the cells in the kidney.
    The growth of the market is attributed to increasing incidence of kidney cancers and increasing ill lifestyle changes which gets worsen with addiction of tobacco and alcohol. Furthermore, overexposure to radiation during treatment testicular cancer, growing awareness program, and increasing mortality due to kidney cancer are boosting the kidney cancer market.
    Over the next five years, projects that Kidney Cancer will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

    In this report, studies the present scenario (with the base year being 2017) and the growth prospects of global Kidney Cancer market for 2018-2023.

    This report presents a comprehensive overview, market shares and growth opportunities of Kidney Cancer market by product type, application, key companies and key regions.

    To calculate the market size, considers value generated from the sales of the following segments:

    Segmentation by product type:
    Renal Cell Carcinoma (RCC)
    Transitional Cell Carcinoma (TCC)
    Segmentation by application:
    Surgery
    Immunotherapy
    Chemotherapy
    Radiation Therapy

    We can also provide the customized separate regional or country-level reports, for the following regions:
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries

    The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
    Merck
    Novartis
    AstraZeneca
    Bristol-Myers Squibb
    Pfizer
    Roche
    Amgen
    Argos Therapeutics
    Aveo Pharmaceuticals
    Bayer
    Exelixis
    Incyte
    Allergan

    In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

    Research objectives
    To study and analyze the global Kidney Cancer market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
    To understand the structure of Kidney Cancer market by identifying its various subsegments.
    Focuses on the key global Kidney Cancer players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Kidney Cancer with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the size of Kidney Cancer submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.